A detailed history of First Horizon Advisors, Inc. transactions in 10x Genomics, Inc. stock. As of the latest transaction made, First Horizon Advisors, Inc. holds 2,910 shares of TXG stock, worth $41,642. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,910
Previous 1,898 53.32%
Holding current value
$41,642
Previous $36,000 80.56%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$15.71 - $23.49 $15,898 - $23,771
1,012 Added 53.32%
2,910 $65,000
Q2 2024

Jul 19, 2024

BUY
$19.45 - $37.37 $15,715 - $30,194
808 Added 74.13%
1,898 $36,000
Q1 2024

Apr 26, 2024

BUY
$36.08 - $54.3 $8,803 - $13,249
244 Added 28.84%
1,090 $40,000
Q4 2023

Feb 06, 2024

BUY
$34.32 - $57.55 $2,059 - $3,453
60 Added 7.63%
846 $47,000
Q3 2023

Oct 27, 2023

SELL
$40.86 - $62.98 $11,318 - $17,445
-277 Reduced 26.06%
786 $32,000
Q2 2023

Aug 03, 2023

SELL
$50.96 - $58.72 $21,454 - $24,721
-421 Reduced 28.37%
1,063 $59,000
Q1 2023

May 15, 2023

SELL
$35.33 - $55.79 $4,981 - $7,866
-141 Reduced 8.68%
1,484 $82,000
Q4 2022

Feb 10, 2023

BUY
$24.4 - $41.3 $9,882 - $16,726
405 Added 33.2%
1,625 $59,000
Q3 2022

Nov 09, 2022

BUY
$28.48 - $52.59 $13,556 - $25,032
476 Added 63.98%
1,220 $34,000
Q2 2022

Aug 02, 2022

BUY
$36.95 - $82.41 $27,306 - $60,900
739 Added 14780.0%
744 $33,000
Q1 2022

May 10, 2022

SELL
$55.7 - $145.79 $17,322 - $45,340
-311 Reduced 98.42%
5 $0
Q4 2021

Feb 09, 2022

BUY
$135.05 - $182.59 $2,565 - $3,469
19 Added 6.4%
316 $47,000
Q3 2021

Nov 15, 2021

SELL
$145.58 - $192.14 $556,552 - $734,551
-3,823 Reduced 92.79%
297 $43,000
Q3 2021

Nov 09, 2021

BUY
$145.58 - $192.14 $565,723 - $746,656
3,886 Added 1660.68%
4,120 $599,000
Q2 2021

Aug 09, 2021

BUY
$134.22 - $202.37 $15,703 - $23,677
117 Added 100.0%
234 $45,000
Q1 2021

May 11, 2021

BUY
$140.25 - $196.86 $16,409 - $23,032
117 New
117 $21,000

Others Institutions Holding TXG

About 10x Genomics, Inc.


  • Ticker TXG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 95,046,400
  • Market Cap $1.36B
  • Description
  • 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...
More about TXG
Track This Portfolio

Track First Horizon Advisors, Inc. Portfolio

Follow First Horizon Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Horizon Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on First Horizon Advisors, Inc. with notifications on news.